首页> 美国卫生研究院文献>Purinergic Signalling >The P2X7 receptor and intracellular pathogens: a continuing struggle
【2h】

The P2X7 receptor and intracellular pathogens: a continuing struggle

机译:P2X7受体和细胞内病原体:持续的斗争

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purinergic receptor, P2X7, has recently emerged as an important component of the innate immune response against microbial infections. Ligation of P2X7 by ATP can stimulate inflammasome activation and secretion of proinflammatory cytokines, but it can also lead directly to killing of intracellular pathogens in infected macrophages and epithelial cells. Thus, while some intracellular pathogens evade host defense responses by modulating with membrane trafficking or cell signaling in the infected cells, the host cells have also developed mechanisms for inhibiting infection. This review will focus on the effects of P2X7 on control of infection by intracellular pathogens, microbial virulence factors that interfere with P2X7 activity, and recent evidence linking polymorphisms in human P2X7 with susceptibility to infection.
机译:嘌呤能受体P2X7最近已成为针对微生物感染的先天免疫应答的重要组成部分。 ATP连接P2X7可以刺激炎症小体的活化和促炎细胞因子的分泌,但它也可以直接导致杀死感染的巨噬细胞和上皮细胞中的细胞内病原体。因此,尽管一些细胞内病原体通过调节被感染细胞中的膜运输或细胞信号转导来逃避宿主防御反应,但宿主细胞也已经开发出抑制感染的机制。这项审查将侧重于P2X7在控制细胞内病原体感染,影响P2X7活性的微生物毒力因子的控制上的作用,以及有关人类P2X7多态性与感染易感性相关的最新证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号